Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
E C OldfieldJ D Berman

Abstract

We conducted a randomized, double-blind, placebo-controlled multicenter trial of azithromycin (1,200 mg once weekly) for the prevention of Mycobacterium avium complex (MAC) infection in patients with AIDS and a CD4 cell count of < 100/mm3. In an intent-to-treat analysis through the end of therapy plus 30 days, nine (10.6%) of 85 azithromycin recipients and 22 (24.7%) of 89 placebo recipients developed MAC infection (hazard ratio, 0.34; P = .004). There was no difference in the ranges of minimal inhibitory concentrations of either clarithromycin or azithromycin for the five breakthrough (first) MAC isolates from the azithromycin group and the 18 breakthrough MAC isolates from the placebo group. Of the 76 patients who died during the study, four (10.5%) of 38 azithromycin recipients and 12 (31.6%) of 38 placebo recipients had a MAC infection followed by death (P = .025). For deaths due to all causes, there was no difference in time to death or number of deaths between the two groups. Episodes of non-MAC bacterial infection per 100 patient years occurred in 43 azithromycin recipients and 88 placebo recipients (relative risk, 0.49; 95% confidence interval, 0.33-0.73). The most common toxic effect noted during the study was gastroin...Continue Reading

Citations

Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Joanne M WolterJoseph G McCormack
Mar 26, 2011·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C HerzmannC Lange
Oct 10, 2002·Clinics in Chest Medicine·Denis Jones, Diane V Havlir
Sep 28, 2001·International Journal of Antimicrobial Agents·E Rubinstein
Apr 14, 2005·Archivos de bronconeumología·J M García GarcíaA A Sánchez Antuña
Dec 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E L MurphyS Krubel
Mar 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M S DworkinUNKNOWN Adult and Adolescent Spectrum of HIV Disease Project
Jan 5, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter PhillipsJulio Montaner
Oct 30, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John H KempenJames Tonascia
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Karen Doucette, Jay A Fishman
Mar 23, 2006·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Anthony J HickeyJason Stout
Oct 28, 2009·Antimicrobial Agents and Chemotherapy·Sam SalmanTimothy M E Davis
Oct 16, 2001·Antimicrobial Agents and Chemotherapy·A BentouchaJ Grosset
Apr 17, 2001·Antimicrobial Agents and Chemotherapy·R HafnerUNKNOWN DATRI 001B Study Group
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·Walter R TaylorJosh Berman
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Aug 6, 1999·Journal of Clinical Pharmacology·G FouldsG Apseloff
Dec 18, 2008·Malaria Journal·R Matthew ChicoDaniel Chandramohan
Jul 9, 2011·Expert Opinion on Drug Metabolism & Toxicology·R Matthew Chico, Daniel Chandramohan
Apr 12, 2011·Tropical Medicine & International Health : TM & IH·R Matthew Chico, Daniel Chandramohan
Aug 17, 2004·Infectious Disease Clinics of North America·Jerry M Zuckerman
Nov 30, 1998·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·S D Shafran
Sep 1, 2004·The Lancet Infectious Diseases·Petros C KarakousisRichard E Chaisson
Sep 19, 2015·The European Respiratory Journal·Nicholas WintersDick Menzies
May 12, 2010·Expert Review of Anti-infective Therapy·Roly D GoslingDaniel Chandramohan
May 30, 2019·Transactions of the Royal Society of Tropical Medicine and Hygiene·Oriyomi AkinyotuAyodele Arowojolu
May 2, 2013·The Cochrane Database of Systematic Reviews·Muhammed Mubashir B UthmanIsmail Yahaya
Jan 19, 2019·The Cochrane Database of Systematic Reviews·Malene Plejdrup HansenChris B Del Mar
Dec 12, 2013·Progress in Orthodontics·Andressa Otranto de Britto TeixeiraMarco Antonio de Oliveira Almeida
Dec 15, 2018·Journal of Cellular Physiology·Mohsen HeidaryDavood Darban-Sarokhalil
Dec 15, 2018·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Mark Kristoffer U PasayanRossana A Ditangco
Apr 22, 2017·Microbiology Spectrum·Charles L Daley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.